The largest database of trusted experimental protocols

14 protocols using ifn γ elispot assay kit

1

IFN-γ ELISPOT Assay for Evaluating Splenocyte Responses

Check if the same lab product or an alternative is used in the 5 most similar protocols
The IFN-γ secreted by re-stimulated splenocytes against target cancer cells was examined using an IFN-γ ELISPOT assay kit (BD Biosciences). Ninety-six well PVDF membrane ELISPOT plates (Millipore, USA) were coated with the capture-purified anti-mouse IFN-γ antibody overnight at 4°C. Then, RPMI medium supplemented with 10% FBS was added to saturate the treated antibody. The re-stimulated splenocytes from the immunized mice were co-cultured with the target cells (GL261 and YAC-1 cell line) at a 10:1 ratio. Co-cultured cells were incubated in 10% FBS-RPMI medium for 24 h at 37°C in an atmosphere of 5% CO2. Subsequently, the plates were incubated for 2 h with the biotinylated detection anti-mouse IFN-γ antibody and then for 1 h with streptavidin-HRP. After washing, spots were revealed using an AEC substrate reagent set (BD Bioscience) and measured on an automatic CTL Immunospot Analyzer (Cellular Technology Ltd., Shaker Heights, OH, USA).
+ Open protocol
+ Expand
2

T Cell Priming Assay for MC38 Tumors

Check if the same lab product or an alternative is used in the 5 most similar protocols
Spleen or draining LN were isolated from MC38 tumor-bearing mice. Single cell suspensions were prepared. Cells (4 × 105) were cultured for 24 h. In T cell priming assay, purified DCs (1 × 104) from LN of MC38-SIY tumor-bearing mice were cocultured with naïve T cells (1 × 105) purified from 2 C mice with or without 5 μg/ml SIY peptides for 48 h. ELISPOT assay was performed using an IFN-γ ELISPOT assay kit (BD Biosciences) according to manufacturer’s instruction. Spots were enumerated by ImmunoSpot Analyzer (CTL).
+ Open protocol
+ Expand
3

IFN-γ ELISPOT Assay for Evaluating Immune Responses

Check if the same lab product or an alternative is used in the 5 most similar protocols
IFN-γ ELISPOT assay kit (BD Biosciences, USA) was used as described by the manufacturer. Plates were coated with anti-IFN-γ mAb overnight at 4°C and then blocked with RPMI 1640 medium containing 10% fetal bovine serum (FBS) for 1 h at room temperature. Splenocytes (2.5 × 105 cells/well) from immunized mice were isolated, plated, and cultured with 10 μg/mL PPD (Statens Serum Institute, Denmark) or 2 μg/mL recombinant Ag85A, 6 μg/mL recombinant ESAT-6 to provide stimulation at 37°C, 5% CO2 for 20 h. After washing the plates with PBS-T20 (1 × PBS, pH 7.4, 0.05% Tween 20), biotinylated anti-IFN-γ was added for 2 h at room temperature. Streptavidin-HRP was added for 45 min, and the color was developed with 3-amino-9-ethylcarbazole (AEC) substrate (BD Biosciences). An immunospot analyzer (Cellular Technology, USA) was used to count the spots.
+ Open protocol
+ Expand
4

Anti-CD20-IFNα Enhances CD8+ T Cell Activation

Check if the same lab product or an alternative is used in the 5 most similar protocols
A20-bearing mice were i.t. treated with 3 μg of anti-CD20-IFNα and control Abs on day 16. Two days later, tumor tissues were digested, and CD8+ T cells were purified by FACS sorting. Approximately 2 × 104 CD8+ T cells and 5 × 104 WT BALB/c mice splenocytes were mixed together with 0.1 mg/ml mitomycin C-treated A20 cells for 44 hours. IFNγ production was determined with an IFNγ ELISPOT assay kit according to the manufacturer’s manual (BD). The visualized cytokine spots were quantified using the ImmunoSpot Analyzer (CTL).
+ Open protocol
+ Expand
5

Quantifying IFN-γ in Tumor Microenvironment

Check if the same lab product or an alternative is used in the 5 most similar protocols
IFN-γ production in tumor microenvironment was detected with IFN-γ ELISPOT assay kit (BD Biosciences, 551881). Tumor tissues were harvested at 8-12 days after transplantation. Tumor tissues were digested with DNase I (Calbiochem) and Liberase TL (Roche) at 37 °C for at least 1 h. The cell suspension was passed through a 70 μm filter (ThermoFisher Scientific) and pelleted by centrifugation at 1500 rpm for 5 min. The cell pellets were resuspended by red blood cell lysate (Solarbio) on ice for 15 minutes to remove red blood cells. Then cell suspension was centrifugated at 1500 rpm for 5 min and washed by PBS twice. 2 × 106 cells were seeded per well in a pre-coated with purified anti-mouse IFNγ antibody (1:200) plate (EMD Millipore) and incubated incubator with 5% CO2 at 37 °C for 16-24 hours. The next day, cell supernatant was removed, and the plate was washed by 1640 medium containing 10% FBS once and then blocked with 1640 medium to block nonspecific sites of antibody. Then plate was treated with biotinylated anti-mouse IFNγ antibody (BD, #511818KZ) for 2 h and streptavidin-HRP for 1 h respectively. The reaction stopped by adding final substrate solution. The plate was scanned using CTL ImmunoSpot® S6 Analyzers (CTL and CTL Analyzers, LLC) and red dots were counted after washed with ddH2O and completely dry.
+ Open protocol
+ Expand
6

Quantifying IFN-γ Responses to Mycobacterial Antigens

Check if the same lab product or an alternative is used in the 5 most similar protocols
The IFN-γ ELISpot assay kit (BD Biosciences, San Jose, CA, USA) was used to determine Ag85B and ESAT-6 specific responses of cells isolated from spleens, lungs and cervical lymph nodes using a previously described protocol [23 (link)]. Aliquots (2 × 105) of cells from the different tissues were cultured in duplicate with either Ag85B (5 μg/mL), ESAT-6 (5 μg/mL), or Concanavalin A (5 μg/mL) for 48 h at 37 °C and 5% CO2. Enumeration of spots representing individual cells producing IFN-γ was conducted by Zellnet Consulting Inc., Fort Lee, NJ, USA) using KS-ELISPOT automatic system (Carl Zeiss Inc., Thornwood, NY, USA). Responses were considered positive only when they were above 10 Spot forming Cells (SFC)/2 × 105 input cells and at least twice the number obtained in cells cultured with medium alone.
+ Open protocol
+ Expand
7

Tumor-Infiltrating Lymphocyte ELISPOT Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
KPL-OVA (1×106) cells were injected subcutaneously on the right flank of 6-8 weeks old C57BL/6J mice purchased from Taconic Biosciences. Seven days after treatment started, tumors were harvested and digested into single cells. For each well of a 96-well plate, tumor infiltrated lymphocytes (TILs) were isolated from 3×105 digested single cells by biotin labeling (BioLegend, Cat# 101304) followed by negative immunomagnetic selection (STEMCELL Technologies, Cat# 19860). Isolated TILs were cultured in RPMI 1640 medium supplemented with 10% fetal bovine serum, 2 mmol/l L-glutamine, 100 U/ml penicillin, and 100 μg/ml streptomycin. For antigen specific CD8+ T cell stimulation, 1 μg/ml of SIINFEKL peptide (OVA257-264) or control RAHYNIVTF (E7) peptide were added. After 48 h of incubation, IFN-γ production was determined with an IFN-γ ELISPOT assay kit according to the manufacturer’s protocol (BD Biosciences, Cat# 551083). The visualized spots were enumerated with the CTL-ImmunoSpot® S6 Analyzer (Cellular Technology Limited) and normalized based on digested tumor cell counts.
+ Open protocol
+ Expand
8

Measuring IFNγ Response in Tumor-Draining Lymph Nodes

Check if the same lab product or an alternative is used in the 5 most similar protocols
Draining lymph nodes (DLNs) from tumor-bearing mice were isolated, and single-cell suspensions were prepared. Cells isolated from draining lymph nodes were co-cultured with 5μg/ml OTI or negative control peptide for 48 hours. The IFNγ production was determined with an IFNγ ELISPOT assay kit according to the manufacturer’s protocol (BD Biosciences). The cytokine spots were enumerated with the Immuno-Spot Analyzer (CTL).
+ Open protocol
+ Expand
9

IFN-γ Production Assay for A20 Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Spleen or lymph node (LN) cells were resuspended in RPMI 1640 medium supplemented with 10% fetal bovine serum, 2 mmol/l L-glutamine, 100 U/ml penicillin, and 100 μg/ml streptomycin. A total of 3*105 spleen or 2*105 LN cells were used for the assay. A20 cells were irradiated with a single dose of 60Gys (10Gys/min for 6 minutes). The ratio of A20 and spleen or LN cells was 1:4. After 48 hours of incubation, the IFN-γ production was determined with an IFN-γ ELISPOT assay kit according to the manufacturer’s protocol (BD Biosciences). The visualized cytokine spots were enumerated with the ImmunoSpot Analyzer (CTL).
+ Open protocol
+ Expand
10

IFN-γ Production in Tumor-Specific T Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
dLN cells were resuspended in RPMI 1640 medium supplemented with 10% FBS, 2 mmol/L l-glutamine, 100 U/mL penicillin, and 100 mg/mL streptomycin. A total of 3 × 105 dLN cells was used for the assay. A20 cells were irradiated with a single dose of 60 Gy. The ratio of A20 to immune cells was 1:4. After 48 hours of incubation, IFN-γ production was determined with an IFN-γ ELISPOT Assay Kit (BD Biosciences) according to the manufacturer’s protocol. The visualized cytokine spots were enumerated with an ImmunoSpot S6 Analyzer (Cellular Technology Limited).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!